DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
QUEST DIAGNOSTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026
$234.91−0.09 (-0.04%)
Close on Oct 19, 2026
- Market cap
- $26.31B
- P/E (TTM)
- 25.0
- Dividend yield
- –
Quest Diagnostics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Market Cap | $25.93B | $1.11B |
| Enterprise Value | $31.25B | $1.41B |
| PE Ratio | 24.96 | 22.72 |
| PS Ratio | 2.24 | 1.60 |
| PB Ratio | 3.45 | 3.03 |
| P/FCF Ratio | 19.22 | 20.54 |
| P/OCF Ratio | 13.62 | 15.44 |
Enterprise value
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| EV / Sales | 2.70 | 1.69 |
| EV / EBITDA | 14.14 | 14.40 |
| EV / EBIT | 19.17 | 19.04 |
| EV / FCF | 23.16 | 23.16 |
Income (trailing twelve months)
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Revenue | $11.56B | $561.90M |
| Gross Profit | $3.83B | $173.32M |
| Operating Income | $1.63B | -$1.81M |
| Pretax Income | $1.40B | -$572.42K |
| Net Income | $1.06B | -$1.16M |
| EBITDA | $2.21B | -$20.72K |
| EPS (Diluted) | $9.41 | -$0.02 |
Margins
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Gross Margin | 33.1% | 33.1% |
| Operating Margin | 14.1% | -4.45% |
| Pretax Margin | 12.1% | 1.54% |
| Profit Margin | 9.19% | -2.91% |
| EBITDA Margin | 19.1% | 2.41% |
| FCF Margin | 11.7% | 3.13% |
Returns
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Return on Equity (ROE) | 14.4% | 1.84% |
| Return on Assets (ROA) | 6.45% | -3.06% |
| Return on Invested Capital (ROIC) | 10.0% | 2.11% |
| Return on Capital Employed (ROCE) | 10.8% | -0.57% |
Growth
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 9.87% | 6.92% |
| Net Income Growth (YoY) | 11.8% | 19.6% |
| EPS Growth (YoY) | 13.2% | 25.8% |
| FCF Growth (YoY) | 10.2% | -6.04% |
| Revenue Growth (3Y CAGR) | 3.74% | 10.9% |
| Revenue Growth (5Y CAGR) | 3.18% | 13.2% |
| EPS Growth (3Y CAGR) | 3.16% | 19.8% |
| EPS Growth (5Y CAGR) | -3.53% | 9.29% |
Balance sheet
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $626.00M | $48.71M |
| Total Debt | $5.64B | $140.00M |
| Net Cash (Debt) | -$5.02B | $205.49K |
| Net Cash Per Share | -$45.45 | $0.01 |
| Equity (Book Value) | $7.52B | $235.16M |
| Book Value Per Share | $68.10 | $3.48 |
| Tangible Book Value | -$3.27B | $703.69K |
| Working Capital | $1.06B | $30.48M |
Financial position
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Current Ratio | 1.59 | 1.40 |
| Quick Ratio | 1.28 | 1.02 |
| Debt / Equity | 0.75 | 0.66 |
| Debt / EBITDA | 2.55 | 2.61 |
| Debt / FCF | 4.18 | 4.59 |
| Net Debt / EBITDA | 2.27 | 2.15 |
Cash flow (trailing twelve months)
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Operating Cash Flow | $1.90B | $3.10M |
| Capital Expenditures | -$554.00M | -$18.62M |
| Free Cash Flow | $1.35B | $23.73M |
| FCF Per Share | $12.22 | $0.37 |
Efficiency
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Asset Turnover | 0.70 | 0.87 |
| Inventory Turnover | 36.82 | 11.67 |
| Revenue Per Employee | $202.81K | $228.48K |
| Profits Per Employee | $18.63K | -$5.75K |
| Employee Count | 57,000 | 910 |
Dividends and yields
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Earnings Yield | 4.10% | -0.59% |
| FCF Yield | 5.20% | 1.74% |
| Payout Ratio | 34.2% | 14.1% |
| FCF Payout Ratio | 26.9% | 12.0% |
Shares
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Shares Outstanding | 110,373,000 | 58,282,400 |
| Shares Change (YoY) | -1.10% | 2.68% |
| Float | 109,859,000 | 33,780,100 |
| Shares Held by Insiders | 0.47% | 16.4% |
| Shares Held by Institutions | 95.1% | 85.9% |
Taxes
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Income Tax | $320.00M | $697.00K |
| Effective Tax Rate | 22.8% | 23.1% |
Scores
| Measure | Quest Diagnostics | Industry median |
|---|---|---|
| Graham Number | $120.07 | $19.59 |
| Graham Upside | -48.9% | -47.5% |
| Altman Z-Score | 3.64 | 2.05 |
| Piotroski F-Score | 7 | 5 |
| Beneish M-Score | -2.65 | -2.71 |
Calculated by StockData from Quest Diagnostics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.